// App-Quantinova.ai

: Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS)

Researchers

Presenter

  • David Leather

Principal Investigators

  • Jorgen Vestbo

  • Nawar Diar Bakerly

  • Joanne L. Fletcher

  • John P. New

  • J. Martin Gibson

  • Sheila Mccorkindale

  • Sue Collier

  • James Lay-Flurrie

  • Lucy Frith

  • Loretta Jacques

  • Catherine Harvey

  • Henrik Svedsater

  • Ashley Woodcock

Medical Centers

  • Respiratory Global Franchise, GSK, Brentford, United Kingdom

  • Centre for Respiratory Medicine and Allergy, Manchester Academic Health Sciences Centre, The University of Manchester and South Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom

  • Salford Royal NHS Foundation Trust, Salford, United Kingdom

  • Respiratory R&D, GSK, Uxbridge, United Kingdom,

  • Salford Royal NHS Foundation Trust, Salford and NorthWest EHealth, Salford, United Kingdom,

  • Manchester Academic Health Science Centre, University of Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

  • NHS Salford Clinical Commissioning Group, Salford, United Kingdom

  • GCSP, CERM, RD Chief Medical Office, GSK, Uxbridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Fluticasone furoate

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved